Fawziah Al Kandari , Andrejs Erglis , Raed Sweidan , Ingrid Dannheimer , Milan Sepsi , Juan Bénézet , Michal Padour , Ajay Naik , Jaime Escudero , Teena West , Reece Holbrook , Faizel Lorgat , On behalf of the PANORAMA investigators
{"title":"Regional variations in baseline characteristics of cardiac rhythm device recipients: The PANORAMA observational cohort study","authors":"Fawziah Al Kandari , Andrejs Erglis , Raed Sweidan , Ingrid Dannheimer , Milan Sepsi , Juan Bénézet , Michal Padour , Ajay Naik , Jaime Escudero , Teena West , Reece Holbrook , Faizel Lorgat , On behalf of the PANORAMA investigators","doi":"10.1016/j.ijchv.2014.06.008","DOIUrl":null,"url":null,"abstract":"<div><h3>Background</h3><p>The PANORAMA study was designed to collect concurrent data on subjects from different worldwide regions implanted with CRM devices.</p></div><div><h3>Methods</h3><p>In this prospective, multi-center study, we analyzed baseline data on 8586 subjects implanted with CRM devices with no additional selection criteria (66% pacemaker (IPG), 16% implantable cardiac defibrillators (ICD), 17% cardiac resynchronization therapy (CRT) and < 1% Internal Loop Recorder) from 156 hospitals across 6 geographical regions between 2005 and 2011.</p></div><div><h3>Results</h3><p>Regardless of the device implanted, subjects from the Middle East and India often had more diabetes than other regions. Eastern and Western Europe had higher rates of atrial fibrillation reported, and men were more likely to smoke than women (46% vs 11%, p < 0.001). Within the CRT cohort there was significant variation in the proportion of males receiving a device, ranging from 55% in India to 83% in Eastern Europe.</p></div><div><h3>Conclusions</h3><p>We provide comprehensive descriptive data on patients receiving CRM devices from a range of geographies that are not typically reported in literature. We found significant variations in clinical characteristics and implant practices. Long term follow-up data will help evaluate if these variations require adjustments to outcome expectations.</p></div>","PeriodicalId":90542,"journal":{"name":"International journal of cardiology. Heart & vessels","volume":"4 ","pages":"Pages 90-96"},"PeriodicalIF":0.0000,"publicationDate":"2014-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.ijchv.2014.06.008","citationCount":"6","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"International journal of cardiology. Heart & vessels","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2214763214000479","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 6
Abstract
Background
The PANORAMA study was designed to collect concurrent data on subjects from different worldwide regions implanted with CRM devices.
Methods
In this prospective, multi-center study, we analyzed baseline data on 8586 subjects implanted with CRM devices with no additional selection criteria (66% pacemaker (IPG), 16% implantable cardiac defibrillators (ICD), 17% cardiac resynchronization therapy (CRT) and < 1% Internal Loop Recorder) from 156 hospitals across 6 geographical regions between 2005 and 2011.
Results
Regardless of the device implanted, subjects from the Middle East and India often had more diabetes than other regions. Eastern and Western Europe had higher rates of atrial fibrillation reported, and men were more likely to smoke than women (46% vs 11%, p < 0.001). Within the CRT cohort there was significant variation in the proportion of males receiving a device, ranging from 55% in India to 83% in Eastern Europe.
Conclusions
We provide comprehensive descriptive data on patients receiving CRM devices from a range of geographies that are not typically reported in literature. We found significant variations in clinical characteristics and implant practices. Long term follow-up data will help evaluate if these variations require adjustments to outcome expectations.
PANORAMA研究旨在收集来自全球不同地区植入CRM设备的受试者的并发数据。方法在这项前瞻性、多中心研究中,我们分析了8586名植入CRM设备的受试者的基线数据,这些设备没有额外的选择标准(66%的起搏器(IPG), 16%的植入式心脏除颤器(ICD), 17%的心脏再同步化治疗(CRT)和<2005年至2011年期间,来自6个地理区域156家医院的数据(1%内部循环记录器)。结果无论植入何种设备,来自中东和印度的受试者通常比其他地区的受试者患糖尿病的几率更高。据报道,东欧和西欧的房颤发病率较高,男性吸烟的可能性高于女性(46% vs 11%, p <0.001)。在CRT队列中,男性接受装置的比例有显著差异,从印度的55%到东欧的83%不等。结论:我们提供了来自不同地区的患者接受CRM设备的全面描述性数据,这些数据在文献中通常没有报道过。我们发现临床特征和种植方法有显著差异。长期随访数据将有助于评估这些差异是否需要调整对结果的预期。